Boston Scientific has appointed Craig Thompson as its new senior vice president chief medical officer of interventional cardiology. The company reports that Thompson will play a key role in driving the development of innovative medical solutions within the Boston Scientific interventional cardiology business and states that he is a global leader in complex cardiac interventions.
According to a press release, Thompson previously served as director, invasive cardiology and vascular medicine, Yale New Haven Hospital, USA, and as associate professor of medicine, Yale University School of Medicine, USA. He has also served as an advisor for many cardiovascular device companies and he participated in the early development of technologies for the treatment of coronary total occlusions, including the BridgePoint coronary chronic total occlusion system acquired by Boston Scientific in 2012.
“Craig is a very experienced interventional cardiologist who is an important addition to our clinical team, increasing our ability to innovate medical solutions that provide unique value to physicians and patients,” said Keith Dawkins, executive vice president and global chief medical officer, Boston Scientific.